about
Absence of gemin5 from SMN complexes in nuclear Cajal bodiesCommonality amid diversity: Multi-study proteomic identification of conserved disease mechanisms in spinal muscular atrophyApoE isoform-specific regulation of regeneration in the peripheral nervous systemThe rat striatum responds to nigro-striatal degeneration via the increased expression of proteins associated with growth and regeneration of neuronal circuitryCross-Reactivity between Schistosoma mansoni Antigens and the Latex Allergen Hev b 7: Putative Implication of Cross-Reactive Carbohydrate Determinants (CCDs)Contaminants in commercial preparations of 'purified' small leucine-rich proteoglycans may distort mechanistic studies.Spinal Muscular Atrophy Patient iPSC-Derived Motor Neurons Have Reduced Expression of Proteins Important in Neuronal Development.Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy.Naturally occurring plant polyphenols as potential therapies for inherited neuromuscular diseases.Anti-epileptic drugs and bone loss: Phenytoin reduces pro-collagen I and alters the electrophoretic mobility of osteonectin in cultured bone cells.Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation.The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood.Valproate reduces collagen and osteonectin in cultured bone cells.Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells.A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy.Human mesenchymal stem cells stimulate EaHy926 endothelial cell migration: combined proteomic and in vitro analysis of the influence of donor-donor variabilityGene expression profiling of the dorsolateral and medial orbitofrontal cortex in schizophrenia.Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivoThe influence of storage parameters on measurement of survival motor neuron (SMN) protein levels: implications for pre-clinical studies and clinical trials for spinal muscular atrophy.Uphold standards for lab reagents.IPSE/alpha-1: a major immunogenic component secreted from Schistosoma mansoni eggs.Two Cases of Spinal Muscular Atrophy Type II with Eosinophilic Oesophagitis.Monoclonal antibody Py recognizes neurofilament heavy chain and is a selective marker for large diameter neurons in the brain.Stathmin is enriched in the developing corticospinal tract.Two independent proteomic approaches provide a comprehensive analysis of the synovial fluid proteome response to Autologous Chondrocyte Implantation.Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA)Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assaysCurrent research on SMN protein and treatment strategies for spinal muscular atrophyProteomic analysis of age-related changes in ovine cerebrospinal fluidA Systematic Review and Meta-Analysis of the Effectiveness of Surgical Decompression in Treating Patients with Malignant Middle Cerebral Artery InfarctionQuantitative proteomic profiling of the rat substantia nigra places glial fibrillary acidic protein at the hub of proteins dysregulated during aging: Implications for idiopathic Parkinson's diseaseMolecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular AtrophyLamin A/C dysregulation contributes to cardiac pathology in a mouse model of severe spinal muscular atrophy
P50
Q21284155-AB96E180-8A1D-42E5-87EC-F49B6888EE15Q26741505-6FE95169-C6CE-4029-9691-DB97849E58C7Q31004893-5E615384-3C1F-4148-B174-590749C644BCQ33613315-42D88059-7C9F-443A-89BD-98905F20FA9AQ36088555-0C3806D3-F6E9-43F8-9FB3-64C2A3D85E1EQ36228943-EB3777ED-DFA2-4DBA-BABD-F85B2B5AB3FBQ36448195-D3D8595C-FD4C-4847-ACCF-EDF1D2E6220BQ37679959-45FE381C-52B5-4D75-AF29-2C307DA5171FQ38161550-D41BABC6-251C-484A-A46D-E800AD705F9CQ38784421-313D6579-8D34-47B8-AC24-9E07E28828C8Q38850056-5333098C-5F7E-456B-AC51-34C00F732651Q39044367-AA70E212-4832-42C7-874C-D21DA1195851Q39117011-5BB056A9-5E8E-4673-B5F2-4596FCFFBF71Q39689799-B36CB976-BC83-45E9-B269-D02EB7774A8CQ39960453-5B7E5E41-BDB5-4A4B-A9F1-F3CEB58A74FBQ40713993-0702AFFB-F4DB-4305-B4E1-C0847BFAFF8CQ41874352-166EF3FA-9291-4B8C-BC73-D1921ED5EBE3Q42069362-B4BBF18B-838E-45B0-B91C-B92390297D8BQ45867040-EF5899E1-1C93-4668-BF54-41E711478271Q46898031-0EBCD88A-C5F7-4FBB-AA9F-C9A47E1C0BDAQ48099622-8478E5EA-D2C3-486D-A3F9-F9525353CDE1Q48591135-AA3EE824-39DD-4710-9C92-D0EF698D7681Q48672065-4B9F65D5-9177-4583-BEFF-3A596E1942EAQ52149281-6E9564DA-701D-40A4-ADE4-A59D278E794EQ55093434-B183C6C9-B1EF-42D6-827F-560FA04AC192Q60918123-AEE1CD5E-33A1-4B75-8764-0A1EA63F9374Q83142880-84F0E796-CEC6-45BA-947E-58565E91BB2EQ84705229-4E48719C-C0A6-4F38-86AF-61FFB0EBE200Q88500613-D7F8ECEF-7923-43E0-B9EF-BD08A9581009Q91334873-F574B86F-CE21-47B8-9A9B-3C53EB4019FAQ91752483-80A86C5E-BAFE-402F-BA50-F94B1AE1F842Q91879523-285508E4-86F5-4BDC-817D-3EEB7CA1C9ABQ92521952-E9781AA7-9D96-4A3C-AF40-3DB2B5B22A34
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Heidi R Fuller
@ast
Heidi R Fuller
@en
Heidi R Fuller
@es
Heidi R Fuller
@nl
type
label
Heidi R Fuller
@ast
Heidi R Fuller
@en
Heidi R Fuller
@es
Heidi R Fuller
@nl
prefLabel
Heidi R Fuller
@ast
Heidi R Fuller
@en
Heidi R Fuller
@es
Heidi R Fuller
@nl
P106
P31
P496
0000-0002-2858-869X